首页 | 本学科首页   官方微博 | 高级检索  
     

头孢哌酮舒巴坦钠治疗医院获得性肺炎的疗效观察
引用本文:周家杰. 头孢哌酮舒巴坦钠治疗医院获得性肺炎的疗效观察[J]. 河北医学, 2012, 18(3): 356-358
作者姓名:周家杰
作者单位:广西省宾阳县第九人民医院,广西,宾阳,530400
摘    要:
目的 探讨头孢哌酮舒巴坦钠治疗社区获得性肺炎的临床疗效和不良反应,为社区获得性肺炎的治疗提供依据.方法 将我院收治并诊断为社区获得性肺炎的病例76例随机分为研究组和对照组,每组38例,两组均给予社区获得性肺炎的常规治疗,对照组患者应用左氧氟沙星200mg/次,静脉滴注,每日2次,疗程5-7d.研究组患者应用头孢哌酮舒巴坦钠2g/次,静脉滴注,每日两次,疗程5-7d.观察两组患者临床疗效和治疗期间不良反应发生情况.结果:研究组体温恢复正常时间为(16.5±1.3)h,总有效率为97.4%(37/38);对照组体温恢复正常时间为(28.5±1.5)h,总有效率为81.6%(31/38),两组数据间比较有统计学差异(P<0.05);研究组不良反应发生率为7.9%,对照组不良反应发生率为10.5%,两组患者不良反应发生率无统计学差异(P>0.05).结论:头孢哌酮舒巴坦钠治疗社区获得性肺炎的临床疗效较好,不良反应较低,值得临床推广应用.

关 键 词:社区获得性肺炎  头孢哌酮舒巴坦钠  左氧氟沙星

A Survey of Cefoperazone Sulbactam Sodium Treatment of Hospital-acquired Pneumonia
ZHOU Jiajie. A Survey of Cefoperazone Sulbactam Sodium Treatment of Hospital-acquired Pneumonia[J]. Hebei Medicine, 2012, 18(3): 356-358
Authors:ZHOU Jiajie
Affiliation:ZHOU Jiajie(The Ninth Hospital of Binyang,Guangxi Binyang530400,China)
Abstract:
Objective: To investigate the clinical efficacy and adverse reactions of cefoperazone sulbactam sodium in the treatment of community-acquired pneumonia.Method: 76 cases of community-acquired pneumonia were randomly divided into study group and control group,38 cases in each group,both groups were given community-acquired pneumonia conventional treatment,the control group were given levofloxacin 200mg,intravenous infusion,5 to 7 days for a course.The study group were given cefoperazone sulbactam 2g,intravenous infusion,twice daily,5 to 7 days.Result: The body temperature in the study group returned to normal time(16.5 ± 1.3) h,the total effective rate was 97.4%(37/38);control group,body temperature returned to normal time(28.5 ± 1.5) h,the total effective rate was 81.6%(31 / 38),(P <0.05);study group of adverse reactions was 7.9%,the incidence of adverse in the control group was 10.5%,(P> 0.05).Conclusion: The clinical efficacy of cefoperazone sulbactam sodium treatment of community-acquired pneumonia is better,adverse reactions is less,worthy of clinical application.
Keywords:Community-acquired pneumonia  Cefoperazone sulbactam  Levofloxacin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号